Shennon Biotechnologies

Shennon Biotechnologies

Biotechnology Research

San Francisco, California 2,003 followers

Analyze, understand & manipulate immune cells on the single cell level to develop better treatments for human diseases

About us

ShennonBio has developed a proprietary platform that can profile millions of immune cells functionally at the single cell level at unprecedented throughput and accuracy, which resolves a key bottleneck in immunotherapy. We utilize the platform to functionally profile immune cells and their cognate antigens and apply this knowledge to develop more effective therapies against solid tumors and autoimmune diseases. Based in San Francisco next to UCSF Mission Bay, we are funded by DCVC, Foundation Capital and AV8. www.shennonbio.com

Website
https://www.shennonbio.com
Industry
Biotechnology Research
Company size
11-50 employees
Headquarters
San Francisco, California
Type
Privately Held
Founded
2021
Specialties
Single cell functional profiling, Immunotherapy target discovery, Ultra high throughput analysis, More effective Immunotherapy, and Curative treatments for solid tumors

Locations

Employees at Shennon Biotechnologies

Updates

Similar pages

Funding

Shennon Biotechnologies 1 total round

Last Round

Seed

US$ 13.0M

See more info on crunchbase